← Back to Screener
Advanced Biomed Inc. Common Stock (ADVB)
Price$5.00
Favorite Metrics
Price vs S&P 500 (26W)-59.77%
Price vs S&P 500 (4W)6.17%
Market Capitalization$6.55M
All Metrics
Book Value / Share (Quarterly)$8.76
P/TBV (Annual)4.36x
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-5.65
Price vs S&P 500 (YTD)-21.95%
EPS (TTM)$5.26
10-Day Avg Trading Volume1.94M
EPS Excl Extra (TTM)$5.26
EPS (Annual)$-3.18
ROI (Annual)-93.71%
Cash / Share (Quarterly)$2.42
P/E Basic Excl Extra (TTM)1.49x
ROA (Last FY)-50.04%
EBITD / Share (TTM)$0.80
Cash Flow / Share (Annual)$-5.41
P/B Ratio0.69x
P/B Ratio (Quarterly)0.67x
Net Income / Employee (Annual)$-0
Net Interest Coverage (TTM)-14.60x
ROA (TTM)55.00%
EV / EBITDA (TTM)0.83x
EPS Incl Extra (Annual)$-3.18
Current Ratio (Annual)2.09x
Quick Ratio (Quarterly)2.15x
3-Month Avg Trading Volume0.35M
52-Week Price Return-87.50%
P/E Incl Extra (TTM)1.49x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.78
52-Week High$48.80
EPS Excl Extra (Annual)$-3.18
26-Week Price Return-51.02%
Quick Ratio (Annual)1.09x
13-Week Price Return-27.05%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)8.56x
Enterprise Value$3.932
Revenue / Employee (Annual)$0
Cash / Share (Annual)$2.69
3-Month Return Std Dev136.37%
Net Income / Employee (TTM)$0
ROE (Last FY)-93.71%
Net Interest Coverage (Annual)9.57x
EPS Basic Excl Extra (Annual)$-3.18
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$5.26
ROI (TTM)87.30%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$3.21
Price vs S&P 500 (52W)-122.59%
P/E Ratio (TTM)1.49x
Year-to-Date Return-17.81%
5-Day Price Return-26.72%
EPS Normalized (Annual)$-3.18
Month-to-Date Return5.26%
EBITD / Share (Annual)$-2.64
P/E Excl Extra (TTM)1.49x
EPS Basic Excl Extra (TTM)$5.26
P/TBV (Quarterly)3.23x
P/B Ratio (Annual)4.36x
Book Value / Share (Annual)$3.21
Price vs S&P 500 (13W)-29.92%
Beta2.30x
Revenue / Share (TTM)$0.00
ROE (TTM)87.30%
52-Week Low$3.61
Industry Peers — Health Services(21)
| Symbol | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|
ADVBAdvanced Biomed Inc. Common Stock | — | — | — | 87.30% | $5.00 |
NTRANatera, Inc. Common Stock | — | 35.90% | -13.44% | -15.28% | $207.74 |
LHLabcorp Holdings Inc. | 25.31x | 7.25% | 9.92% | 10.28% | $269.19 |
DGXQuest Diagnostics Inc. | 21.75x | 11.78% | 14.10% | 13.88% | $196.31 |
EXASExact Sciences Corp | — | 17.69% | -6.35% | -8.51% | $104.91 |
GHGuardant Health, Inc. Common Stock | — | 32.88% | -45.02% | -246.60% | $91.07 |
RDNTRadNet, Inc. Common Stock | 1779.27x | 11.51% | 3.04% | -1.88% | $57.85 |
VCYTVeracyte, Inc. | 39.66x | 16.01% | 11.17% | 5.33% | $33.45 |
GRALGRAIL, Inc. Common Stock | — | 17.18% | -381.98% | -17.11% | $51.20 |
CDNACareDx, Inc. | 18.34x | 13.79% | -8.10% | -6.47% | $21.29 |
FTREFortrea Holdings Inc. Common Stock | — | 1.00% | -32.04% | -152.17% | $10.44 |
About
Advanced Biomed Inc develops microfluidic biochip technologies that combine semiconductor and biotechnology expertise for cancer diagnosis and precision treatment. The company offers proprietary device systems (A+Pre, AC-1000, A+CellScan, A+SCDrop) with corresponding biochips designed for early cancer screening, diagnosis, staging, and treatment guidance. These solutions provide rapid, affordable testing to support faster clinical decision-making for cancer patients.